In our continuous R+D processes, Biotech Tricopharming Research, in collaboration with the National Centre for Food Technology and Safety (CNTA), has carried out an evaluation of the antioxidant therapeutic potential of Artennua®, our Artemisia annua plant optimized version, compared to other aromatic and medicinal plants (MAPs) with high antioxidant properties. The evaluation is part of…
Medicinal plant extracts may help into treatments of epidemic diseases like COVID-19 Nowadays it is everyone’s concern about what’s COVID-19 doing to society and what are the chances to fight against it. On March 13th, Nature Plants high-impact international journal came out with an interesting article showing how some well recognized botanical extracts may help…
Thanks to CDTI and our achievement at Cervera project, we have been working on our production platform for biomolecules of Industrial interest. We will continue working on the validation of our biostimulation technology in various species of Medicinal and Aromatic plants (MAPs), as well as we have done with Artemisia annua plant. Learn more about…
Validation of a biostimulation technology able to increase molecules´ and secondary metabolites concentration both in Artemisia annua plant and other Medicinal and Aromatic Plants. The project also pretends to test and validate the therapeutic and functional potential of Artennua® extract. The Centre for the Technological and Industrial Development (CDTI) by Government of Spain, approved our…
